Attached files

file filename
EX-31.1 - EXHIBIT 31.1 - AMPAL-AMERICAN ISRAEL CORPexhibit_31-1.htm
EX-32.1 - EXHIBIT 32.1 - AMPAL-AMERICAN ISRAEL CORPexhibit_32-1.htm
EX-11.1 - EXHIBIT 11.1 - AMPAL-AMERICAN ISRAEL CORPexhibit_11-1.htm
EX-31.2 - EXHIBIT 31.2 - AMPAL-AMERICAN ISRAEL CORPexhibit_31-2.htm
EXCEL - IDEA: XBRL DOCUMENT - AMPAL-AMERICAN ISRAEL CORPFinancial_Report.xls


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
 

FORM 10-Q
 
(Mark One)
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended June 30, 2011
 
OR
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _______________________ to_______________
 
Commission file number 0-538
 
AMPAL-AMERICAN ISRAEL CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

New York
 
13-0435685
(State or Other Jurisdiction of
 
(I.R.S. Employer)
Incorporation or Organization)
 
Identification Number
     
555 Madison Avenue
New York, NY, USA
 
10022
(Address of Principal Executive Offices)
 
(Zip code)
     
Registrant’s Telephone Number, Including Area Code (866) 447-8636
 
Former Name, Former Address and Former Fiscal Year, If Changed Since Last Report.
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
 
Yes x   No  o
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
 
Yes o   No  o
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer", "accelerated filer” and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):
 
 
  Large accelerated filer o     Accelerated filer o
  Non-accelerated filer o (Do not check if a smaller reporting company)          Smaller reporting company x
            
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
 
Yes o   No  x
 
The number of shares outstanding of the issuer’s Class A Stock, par value $1.00 per share, its only authorized common stock, is 56,133,764 (as of July 25, 2011).
 
 
 

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
 
Index to Form 10-Q

       
Page
   
         
   
         
   
1-2
         
   
3-4
         
   
5-6
         
   
7-8
         
   
9-16
         
 
17-25
       
  Item 4.    Controls and Procedures 26
         
 
         
   
27
         
   
27
         
   
27
         
   
27
         
   
27
         
   
27
         
   
27
 
 
 

 
 
ITEM 1. FINANCIAL STATEMENTS
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

ASSETS AS OF
 
June 30,
2011
   
December 31,
2010
 
(U.S. Dollars in thousands)
 
(Unaudited)
   
(Audited)
 
             
Current assets:
           
Cash and cash equivalents
  $ 97,383     $ 33,341  
Marketable securities
    603       890  
Accounts receivable (Net of allowance for doubtful amounts of $2,499 and $2,068, respectively)
    123,279       113,837  
Deposits, notes and loans receivable
    16,004       14,053  
Inventories
    38,942       34,810  
Other assets
    37,767       29,283  
Held for sale assets
    --       412,239  
       Total current assets
    313,978       638,453  
Non-current assets:
               
Investments
    356,492       371,751  
Fixed assets, less accumulated depreciation of $38,712 and $32,633, respectively
    201,038       196,361  
Deposits, notes and loans receivable
    30,866       43,338  
Deferred income taxes
    27,844       41,422  
Other assets
    17,129       18,617  
Goodwill
    73,527       70,670  
Intangible assets
    14,405       17,063  
       Total Non-current assets
   
721,301
      759,222  
                 
TOTAL ASSETS
  $ 1,035,279     $ 1,397,675  
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
1

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

LIABILITIES AND  EQUITY AS OF
 
June 30,
2011
   
December 31,
2010
 
(U.S. Dollars in thousands, except share amounts)
 
(Unaudited)
   
(Audited)
 
             
LIABILITIES
           
Current liabilities:
           
Notes and loans payable and current maturities
  $ 141,637     $ 195,342  
Accounts payable, accrued expenses and others
    96,046       102,104  
Debentures – current maturities
    47,892       14,749  
Held for sale liabilities
    2,974       292,240  
       Total current liabilities
    288,549       604,435  
Long term liabilities:
               
Notes and loans payable
    219,800       218,023  
Notes to partners
    107,326       103,274  
Debentures
    243,931       265,590  
Deferred income taxes
    14,458       13,775  
Other long-term liabilities
    14,872       14,030  
       Total long-term liabilities
    600,387       614,692  
Total liabilities
    888,936       1,219,127  
                 
EQUITY
               
Ampal's shareholders' equity:
               
Class A Stock $1.00 par value; authorized 100,000,000 and 100,000,000 shares, respectively; issued  63,277,321
and 63,277,321 shares, respectively; outstanding 56,133,764 and 56,133,764 shares, respectively
    63,277       63,277  
                 
Additional paid-in capital
    183,260       182,924  
                 
Accumulated deficiency
    (54,413 )     (32,316 )
                 
Accumulated other comprehensive income
    1,045       103  
                 
Treasury stock, at cost
    (28,763 )     (28,763 )
                 
Total Ampal shareholders’ equity
    164,406       185,225  
                 
Noncontrolling interest
    (18,063 )     (6,677 )
                 
Total equity
    146,343       178,548  
                 
TOTAL LIABILITIES AND  EQUITY
  $ 1,035,279     $ 1,397,675  
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
2

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
             
SIX  MONTHS ENDED JUNE 30,
 
2011
      2010(*)  
(U.S. Dollars in thousands, except per share amounts)
 
(Unaudited)
   
(Unaudited)
 
               
REVENUES:
             
Chemical income
  $ 274,171     $ 236,324  
Real estate income
    174       --  
Realized gains on investments
    --       814  
Gain (loss) on sale of fixed assets
    40       (2 )
Realized and unrealized gains on marketable securities
    21       86  
Equity in earnings (loss) of affiliates
    179       (198 )
Interest income
    1,336       272  
Leisure-time income
    1,549       1,470  
Other income
   
1,770
      2,580  
Total revenues
   
279,240
      241,346  
                 
EXPENSES:
               
Chemical expense - cost of goods sold
    249,214       216,515  
Real estate expenses
    300       468  
Loss from impairment of investments
    16,923       --  
Interest expense
    22,659       17,724  
Translation loss (gain)
   
7,256
      (10,612 )
Marketing expenses
   
5,354
      3,939  
General, administrative and other
    30,855       23,884  
        Total expenses
   
332,561
      251,918  
Loss from continuing operations before income taxes
    (53,321 )     (10,572 )
Income tax expenses (benefit)
    14,298       (499 )
Net loss from continuing operations after tax benefits
    (67,619 )     (10,073 )
Discontinued operations:
               
Gain disposal, net of tax
    28,891       --  
Income from discontinued operations, net of tax
    5,175       2,788  
      34,066       2,788  
Net loss
    (33,553 )     (7,285 )
Less: Net loss (gain) attributable to noncontrolling interests
    11,456       (2,687
Net loss attributable to Ampal's shareholders
    (22,097 )     (9,972 )
                 
Basic and diluted EPS:
               
Loss from continuing operations attributable to Ampal's shareholders
    (1.00 )     (0.23 )
Discontinued operations attributable to Ampal's shareholders
    0.61       0.05  
 
  $ (0.39 )   $ (0.18 )
                 
Shares used in EPS calculation (in thousands)
    56,134       56,134  
 
(*) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
3

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
 
THREE MONTHS ENDED JUNE 30,
 
2011
      2010(*)  
(U.S. Dollars in thousands, except per share amounts)
 
(Unaudited)
   
(Unaudited)
 
               
REVENUES:
             
Chemical income
  $ 139,627     $ 118,118  
Real estate income
    62       81  
Realized gains on investments
    --       710  
Gain (loss) on sale of fixed assets
    61       (4 )
Realized and unrealized gains on marketable securities
    8       7  
Equity in losses of affiliates
    (2 )     (215 )
Interest income
    916       136  
Leisure-time income
    882       809  
Gain from redemption of debt and other income
    1,133       8  
Total revenues
    142,687       119,650  
                 
EXPENSES:
               
Chemical expense - cost of goods sold
    123,866       107,787  
Real estate expenses
    124       254  
Loss from impairment of investments
    16,923       --  
Interest expense
    12,960       11,522  
Translation loss (gain)
    3,362       (14,027 )
Marketing expenses
    2,780       1,707  
General, administrative and other
    17,099       12,015  
        Total expenses
    177,114       119,258  
Income (loss) from continuing operations before income taxes
    (34,427 )     392  
Income tax expenses (benefit)
    14,169       (356 )
Net income (loss) from continuing operations after tax benefits
    (48,596 )     748  
Discontinued operations
               
Income from discontinued operations, net of tax
    --       628  
      --       628  
Net income (loss)
    (48,596 )     1,376  
Less: Net loss (gain) attributable to noncontrolling interests
    9,253       (4,218 )
Net loss attributable to Ampal's shareholders
    (39,343 )     (2,842 )
                 
Basic and diluted EPS:
               
Loss from continuing operations attributable to Ampal's shareholders
    (0.70 )     (0.06 )
Discontinued operations attributable to Ampal's shareholders
    --       0.01  
 
  $ (0.70 )   $ (0.05 )
                 
Shares used in EPS calculation (in thousands)
    56,134       56,134  
 
(*) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
4

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
 
SIX MONTHS ENDED JUNE 30,
 
2011
    2010 (*)  
(U.S. Dollars in thousands)
 
(Unaudited)
   
(Unaudited)
 
               
Cash flows from operating activities:
             
Net  loss for the period
  $ (33,553 )   $ (7,285 )
Net income from discontinued operations
    (34,066 )     (2,788 )
Loss from continuing operations
    (67,619 )     (10,073 )
Adjustments to reconcile net loss for the period to net cash used in operating activities:
               
Equity in losses (earnings) of affiliates
    (179 )     198  
Realized and unrealized gain on investments, net
    (21 )     (900 )
Depreciation and amortization expense
    10,579       9,045  
Loss (gain) from sale of fixed assets
    (40 )     14  
Impairment of investment
    16,923       --  
Non cash stock based compensation
    336       636  
Translation loss (gain)
    7,099       (10,612 )
Decrease (increase)  in other assets
    4,110       (7,579 )
Increase  in inventories
    (3,105 )     (1,966 )
Increase in accounts receivable
    (3,359 )     (655 )
Increase  (decrease) in accounts payable, accrued expenses and other
    (7,795 )     11,686  
Gain from repurchase of debentures
    (889 )     --  
Proceeds from sale of trading securities
    318       1,515  
Dividends received from affiliates
    --       332  
                 
Net cash used in operating activities
    (43,642 )     (8,359 )
                 
Cash flows from investing activities:
               
Deposits, notes and loans receivable collected
    11,300       5,356  
Deposits, notes and loans receivable granted
    --       (4,938 )
Purchase and improvements of fixed assets
    (4,595 )     (3,395 )
Investments made in affiliates and others
    --       (1,776 )
Investments made in available-for-sale shares
    --       (6,270 )
Proceeds from sale of available-for-sale shares
    --       18,698  
Acquisition of  noncontrolling interests
    --       (841 )
Proceeds from disposal of investments in Affiliate and others
    --       1,976  
Increase in severance fund
    (421 )     --  
Proceeds from sale of fixed assets
    363       282  
                 
Net cash provided from investing activities
    6,647       9,092  
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
5

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

             
SIX MONTHS ENDED JUNE 30,
 
2011
      2010(*)  
(U.S. Dollars in thousands)
 
(Unaudited)
   
(Unaudited)
 
               
Cash flows from financing activities:
             
Proceeds from notes issued and loans received
  $ 10,202     $ 61,373  
Notes and loans payable repaid
   
(64,997
)     (8,553 )
Debentures repaid
   
(4,962
)     --  
Dividend paid
    --       (1,494 )
Net cash provided by (used in) financing activities
   
(59,757
)     51,326  
                 
Effect of exchange rate changes on cash and cash equivalents
    856       (3,545 )
                 
Cash flows from discontinued operations:
               
Cash provided by (used in) operating activities of discontinued operations
    (18,124 )     23,451  
Cash provided by (used in) investing activities of discontinued operations
    174,085       (331,191 )
Cash provided by (used in) financing activities of discontinued operations
    (3,973 )     211,654  
Effect of exchange rate changes on cash and cash equivalents of discontinued operations
    (901 )     (1,410 )
Net cash provided by (used in) discontinued operations
    151,087       (97,496 )
                 
                 
Net increase (decrease)  in cash and cash equivalents
    55,191       (48,982 )
Cash and cash equivalents at beginning of period (in 2011 including $8,851 from discontinued operations)
    42,192       71,484  
                 
Cash and cash equivalents at end of period
  $ 97,383     $ 22,502  
Less cash and cash equivalents of discontinued operations at end of the period
    --       3,562  
Cash and cash equivalents of continuing operations at end of the period
    97,383       18,940  
 
(*) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
6

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
 
(U.S. Dollars in thousands)
 
Unaudited
 
    Equity attributable to Ampal-American Israel Corporation shareholders              
    Class A Stock                                      
   
Number
of shares*
   
Amount
   
Additional
paid-in
capital
   
Accumulated deficiency
   
Accumulated
other
comprehensive
income
   
Treasury
stock
   
Non-controlling
interests
   
Total
equity
 
                                                 
BALANCE AT JANUARY 1, 2011
    63,277       63,277       182,924       (32,316 )     103       (28,763 )     (6,677 )     178,548  
CHANGES DURING  THE SIX
   MONTHS ENDED JUNE 30, 2011:
                                                               
Net loss for the period
                            (22,097 )                     (11,456 )     (33,553 )
Foreign currency translation adjustments
                                    942               70       1,012  
Total comprehensive income (loss)
                                                            (32,541 )
Share based compensation expense
                    336                                       336  
 BALANCE AT JUNE 30, 2011
    63,277       63,277       183,260       (54,413 )     1,045       (28,763 )     (18,063 )     146,343  
 
* In thousands
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
7

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
 
(U.S. Dollars in thousands)
 
Unaudited
 
    Equity attributable to Ampal-American Israel Corporation shareholders              
    Class A Stock                                      
   
Number
of shares*
   
Amount
   
Additional
paid-in
capital (**)
   
Accumulated deficiency (**)
   
Accumulated
other
comprehensive
income (loss) (**)
   
Treasury
stock
   
Non-controlling
interests (**)
   
Total
equity
 
                                                 
BALANCE AT JANUARY 1, 2010
    63,277       63,277       184,287       12,426       (14,598 )     (28,763 )     (75 )     216,554  
CHANGES DURING  THE SIX
   MONTHS ENDED JUNE 30, 2010:
                                                               
Net loss for the period
                            (9,972 )                     2,687       (7,285 )
Unrealized loss from marketable securities                                     323                       323  
Foreign currency translation adjustments                                     (8,436             (649     (9,085
Total comprehensive loss                                                             (16,047
Acquisition of noncontrolling interests                                     (369                     (369
Dividends paid                     (1,494                                     (1,494
Share based compensation expense
                    622                                       622  
BALANCE AT JUNE 30, 2010
    63,277       63,277       183,415       2,454       (23,080     (28,763 )     1,963       199,266  
 
* In thousands
 
(**) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
The accompanying notes are an integral part of these condensed consolidated financial statements.
 
 
8

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
 
(Unaudited)
 
1.
As used in these financial statements, the term the “Company” refers to Ampal-American Israel Corporation (“Ampal”) and its consolidated subsidiaries.
 
2.
The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States of America, for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the interim period are not necessarily indicative of the results that may be expected for the full year. You should read these interim condensed consolidated financial statements in conjunction with the audited consolidated financial statements in the Annual Report on Form 10-K for the year ended December 31, 2010, filed with the Securities and Exchange Commission.
 
Reference should be made to the Company’s consolidated financial statements for the year ended December 31, 2010 for a description of the critical accounting policies. Also, reference should be made to the notes to the Company’s December 31, 2010 consolidated financial statements for additional information regarding the Company’s consolidated financial condition, results of operations and cash flows.
 
3.
Recently Adopted and Recently Issued Accounting Pronouncements
 
In June 2011, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update No. 2011-05 ("ASU 2011-05") which amended the comprehensive income presentation guidance. The amendment requires entities to report components of comprehensive income in either a continuous statement of comprehensive income or two separate but consecutive statements. The guidance is effective for interim and annual periods beginning after December 15, 2011. The Company is currently evaluating the potential impact of ASU 2011-05 on its financial statements.

In May 2011, the FASB issued Accounting Standards Update No. 2011-04 ("ASU 2011-04") for Fair Value Measurements and Disclosures (Topic 820). The amendment clarifies the existing guidance and adds new disclosure requirements. The guidance is effective for interim and annual periods beginning after December 15, 2011. The Company is currently evaluating the potential impact of ASU 2011-04 on its financial statements.
 
In December 2010, the FASB issued Accounting Standards Update No. 2010-28  (“ASU 2010-28”) for Intangibles - Goodwill and Other (Topic 350 ): "Intangibles - Goodwill and Other: When to Perform Step 2 of the Goodwill Impairment Test for Reporting Units with Zero or Negative Carrying Amounts." ASU 2010-28 impacted reporting units with zero or negative carrying amounts and required an additional test to be performed to determine whether goodwill has been impaired and to calculate the amount of that impairment. The adoption did not have a material impact on the Company's financial statements. The amendments in this Update are effective for fiscal years, and interim periods within those years, beginning after December 15, 2010. Early adoption is not permitted. The adoption did not have a material impact on the Company's financial statements.
 
4.
Cash and cash equivalents
 
Cash equivalents are short-term, highly liquid investments (bank accounts and bank deposits) that have original maturity dates of three months or less and are readily convertible into cash.
 
Cash equivalents equal to $1.0 million have been allocated as a compensating balance for various loans provided to the Company and would therefore be unavailable if the Company wished to pledge them in order to provide an additional source of cash.
 
5.
Inventories – mainly chemicals and other materials intended for sale are valued at the lower of cost or market. Cost is determined based on the moving average basis.
 
6.
East Mediterranean Gas Company
 
As of June 30, 2011, the Company’s financial statements reflect a 16.8% interest in shares of East Mediterranean Gas Co. S.A.E., an Egyptian joint stock company ("EMG"), with 8.2% held directly and 8.6% held through Merhav Ampal Energy Holdings, LP, an Israeli limited partnership of which Ampal owns 50%.

The investment in EMG is accounted for as a cost method investment.
 
The Company evaluates the carrying value amount of its interest in EMG periodically in connection with the preparation of its financial statements.  In light of the recent developments in Egypt, the Company obtained an updated valuation from an independent valuator for the quarters ended June 30, 2011 and March 31, 2011. The periodic independent valuations obtained by the Company to assist in its preparation of financial statements customarily indicate a range of values depending on underlying assumptions.  In the recent independent valuation, due to uncertainties in Egypt, the lower end of the indicated valuation range was materially lower than in the past and lower than the value at which EMG is carried on the Company's balance sheet. Management assessed the investment to determine if the decline in fair value was other than temporary. Based on these assessments, management determined that the decline in fair value of the investment was other than temporary and the Company recorded charges of $16.9 million and decreased deferred income taxes in the amount of $14.1 million. The carrying amount of the investments in EMG as of June 30, 2011 is $344.4 million.
 
 
9

 

The principal factors affecting valuation are the price, quantity, delivery dates and reliability of the gas as well as the discount rate.  An adverse change in any of these factors could result in additional material reduction in the value of EMG and additional reduction in the carrying value amount of the asset on the Company's balance sheet.  The Company will continue to evaluate developments with regard to EMG and will make determinations each fiscal period as to whether an impairment charge is appropriate.
 
EMG organized in 2000 in accordance with the Egyptian Special Free Zones system, has been granted the right to export 7.0 billion cubic meters ("BCM")/year of natural gas from Egypt to Israel, other locations in the East Mediterranean basin and to other countries. EMG has linked the Israeli energy market with the Egyptian national gas grid via an East Mediterranean pipeline with the first gas delivery occurring in May 2008. EMG is the developer, owner and operator of the pipeline and its associated facilities on shore in both the point of departure at El Arish, Egypt and the point of entry in Ashkelon, Israel.
 
This project is governed by an agreement signed between Israel and Egypt which designates EMG as the authorized exporter of Egyptian gas, secures EMG’s tax exemption in Israel and provides for the Egyptian government’s guarantee for the delivery of 7 BCM/year of gas to the Israeli market.

From February 5, 2011 to March 15, 2011, from April 27, 2011 to June 9, 2011 and from July 4, 2011 to July 5, 2011, the supply of gas to EMG, and therefore to EMG’s Israeli clients, was interrupted due to damages in GASCO’s (the Egyptian gas transport company) pipeline serving EMG resulting from three alleged terror attacks on GASCO's gas pipeline. Neither EMG's site nor EMG's pipeline were damaged in the three attacks.
 
On July 12, 2011, the supply of gas to EMG, and therefore to EMG’s Israeli clients, was interrupted due to an explosion in a valve station of GASCO's gas pipeline, approximately 20 kilometers west of EMG's site at Al Arish, due to an alleged terror attack. Following the explosion EGAS  initiated its standard shut down procedure affecting gas transportation throughout the Sinai area and gas supply to Jordan, Lebanon, Syria; to major Egyptian industries and gas consumers in the Sinai; and to EMG.

On July 30, 2011, in the wake of violent incidents in El-Arish, Egypt, there was an attempt to cause damage to the EMG site near El-Arish. The security forces on site returned fire, prevented any penetration of the EMG site and repelled the attack.

EMG reports that the July 30, 2011 incident will not affect its operations once EGPC resumes supply after it was interrupted due to the July 12, 2011 explosion.
 
As a result of the continued interruption of gas supply to EMG and the delivery of gas to EMG below contracted quantities, the international shareholders of EMG, including Ampal, have commenced procedures under applicable bilateral investment treaties between their countries and Egypt. Such procedures may ultimately result in arbitration of claims under the various treaties, its gas supply agreement or other agreements.  Ampal has also been advised by EMG that EMG is considering initiating arbitration proceedings against the government- owned Egyptian gas supplier alleging a breach of various provisions of its gas purchase agreement.
 
7.
Gadot Chemical Tankers and Terminals Ltd. (“Gadot”)
 
Gadot, a wholly owned subsidiary of Ampal (99.99% on a fully diluted basis), was founded in 1958 as a privately held Israeli company with operations in distribution and marketing of liquid chemicals for raw materials used for industrial purposes. Since then, Gadot has expanded into a group of companies, which currently forms Israel’s leading chemical distribution organization. Through its subsidiaries, Gadot ships, stores, and distributes liquid chemicals, oils, and a large variety of materials to countries across the globe, with an emphasis on Israel and Western Europe. In our description of Gadot’s business operations, the term “Gadot” refers to Gadot and its consolidated subsidiaries.
 
Gadot’s business is influenced by certain economic factors, which include (i) global changes in demand for chemicals used as raw materials for industrial purposes, (ii) price fluctuations of chemicals and raw materials, (iii) price fluctuations of shipping costs, ship leases and ship fuel, (iv) general global financial stability, and (v) currency fluctuations between the New Israeli Shekel ("NIS") and other currencies, primarily the U.S. Dollar.
 
Gadot’s operations are divided into three main service sectors:
 
 
·
Importing, marketing and sale of chemicals and other raw materials in Israel and Europe;
 
 
·
Shipping, primarily between the European ports of the Atlantic Ocean and the Mediterranean sea port and agency services for shipping companies and docked ships; and
 
 
·
Logistical services in Israel and Europe.
 
 
10

 
 
These service sectors are synergistic and complementary, so that Gadot provides its customers with a full range of services, from acquiring chemicals based on a customer’s needs, logistical handling including shipping and transport, offloading, storage and delivery. Members of the Gadot group of companies also provide services for other members of the group, strengthening the group as a whole.
 
8.
Discontinued operations
 
On March 3, 2011, Merhav-Ampal Group Ltd. (formerly Merhav-Ampal Energy Ltd.), an Israeli corporation and wholly owned subsidiary of Ampal ("MAG") completed its sale of all of the outstanding shares of 012 Smile Telecom Ltd., a wholly owned subsidiary of MAG ("012") to Partner Communications Company Ltd. ("Partner"), in accordance the Share Purchase Agreement between MAG, 012 and Partner, signed on October 13, 2010 (the “012 Sale”). As part of the 012 Sale, Partner also assumed approximately NIS 800 million (approximately $225.4 million) of the total debt of 012 Smile. Accordingly, 012 Smile has been reported as discontinued operations since December 31, 2010. The 012 Sale closed on March 3, 2011. Partner paid to Ampal approximately NIS 650 million (approximately $180 million) out of which Ampal recorded a gain of $28.9 million, net of an early repayment fee the Company paid in connection with the repayment of a loan received to finance the purchase of 012 and net of tax, from the 012 Sale. In addition the Company recorded income from discontinued operations of $19.9 million in 2010 and $5.2 million in the period ended June 30, 2011.
 
All the indirect interest expenses were recorded as a continuing operation.
 
Classification
 
We classified certain operations as discontinued using GAAP, as the associated operations and cash flows will be eliminated from our ongoing operations and we will not have any significant continuing involvement in their operations after the respective sale transactions. For all periods presented, all of the operating results for these operations were removed from continuing operations and are presented separately as discontinued operations, net of tax. The Notes to the Consolidated Financial Statements were adjusted to exclude discontinued operations unless otherwise noted.
 
9.
Acquisition of Merhav Agro Ltd.
 
 
On July 1, 2010, Gadot, through its subsidiary, completed the acquisition of all of the issued share capital of Merhav Agro Ltd. (“Agro”). Agro is one of the leading suppliers of plant protection products, plant growth regulators and seeds in Israel.
 
 
Upon closing, Gadot paid, as consideration, NIS 108 million (approximately $27.8 million). To fund the purchase price, Gadot obtained a long-term credit facility in the aggregate principal amount of NIS 108 million (approximately $27.8 million) from Israel Discount Bank Ltd.
 
 
The acquisition of Agro was accounted for as a combination of entities under common control, which is similar to the pooling-of-interests method of accounting for business combinations. Accordingly, the consolidated financial statements give retrospective effect to this transaction.
 
 
FASB ASC 805, Business Combinations, excludes transfers of net assets or exchanges of equity interests between entities under common control. ASC 805 also states that transfers of net assets or exchanges of equity interests between entities under common control should be accounted for similar to the pooling-of-interests method (as-if pooling-of-interests) in that the entity that receives the net assets or the equity interests initially recognizes the assets and liabilities transferred at their carrying amounts in the accounts of the transferring entity at the date of transfer. Because Gadot and Agro were under common control at the time of the acquisition, the transfer of assets and liabilities of Agro was accounted for at historical cost in a manner similar to a pooling-of-interests. For financial accounting purposes, the acquisition was viewed as a change in reporting entity and, as a result, required reclassification of the Company's financial statements for all periods subsequent to October 18, 2008, the date on which Agro was acquired. Accordingly, the Company's consolidated balance sheet as of December 31, 2010, the consolidated statements of operations for the six months ended June 30, 2010 and the statements of changes in equity and consolidated statements of cash flows for the six months ended June 30, 2010 were reclassified to include Agro. Agro's financial data has been included in the Chemicals segment.Sugarcane Ethanol Production Project
 
10.
Sugarcane Ethanol Production Project
 
 
On December 31, 2009, Ampal signed an option exercise agreement (the “Exercise Agreement”) with Merhav (M.N.F.) Ltd. (“Merhav”) pursuant to which it exercised, subject to certain conditions, its option (the “Option”) to convert Ampal’s existing loan to Merhav (consisting of $20 million of principal plus accrued interest) (the “Loan”) into a 25% equity interest in the sugarcane ethanol production project in Colombia (the “Project”) being developed by Merhav. The Loan is evidenced by an Amended and Restated Promissory Note, dated December 25, 2008 (the “Note”), issued by Merhav in favor of Ampal, and is secured by Merhav’s pledge of its shares of Class A Stock of Ampal, pursuant to that certain Pledge Agreement, dated December 24, 2007, between Merhav and Ampal (the “Pledge Agreement”). Merhav’s obligations under the Note are guaranteed by Mr. Yosef A. Maiman pursuant to a personal guaranty, dated as of December 25, 2008 (the “Guaranty”). The Option is evidenced by an Option Agreement, dated December 25, 2007, between Merhav and Ampal, as amended on December 25, 2008 (the “Option Agreement”). The Loan, Option and related transactions are summarized in the Company's previously filed annual and periodic reports. On December 31, 2010, all the rights and obligations of Ampal in the Project were assigned to MAG.
 
 
11

 
 
Pursuant to the Exercise Agreement, the conversion of the Loan into a 25% equity interest in the Project will take the form of the issuance to MAG of 25% of all of the issued and outstanding equity interests in Merhav Renewable Energies Limited, a Cyprus corporation and subsidiary of Merhav (“Merhav Energies”). The purchase price for the 25% equity stake in Merhav Energies, to be paid at closing, is the outstanding balance of the Note on December 31, 2009, or approximately $22.3 million. The closing of the purchase of the 25% equity stake and the conversion of the Loan is subject to, among other things, (i) the initial disbursement of (or other evidence of) long term debt financing for the Project obtained from Banco do Brasil or any other unaffiliated third party lender (the date such financing is obtained, the “Qualified Financing Date”), (ii) the payment in full of all outstanding amounts due and payable under the Note, and (iii) the delivery at closing of the Shareholders’ Agreement (as defined below) by Merhav and MAG, setting forth certain agreements relating to the governance of Merhav Energies. At closing, the Note and the Guaranty shall be cancelled and the pledge of Merhav’s shares of Class A Stock under the Pledge Agreement shall be released. The closing was to occur on the Qualified Financing Date or as soon as practicable thereafter, but no later than December 31, 2010 (the "Termination Date"). Since the Qualified Financing Date did not occur prior to December 31, 2010, on December 31, 2010, the parties amended the Exercise Agreement such that the Termination Date and the maturity date of the Note was extended to December 31, 2011.

The Exercise Agreement contains other customary closing conditions, as well as customary representations and warranties.
 
 
Pursuant to the Exercise Agreement, the Note was amended to extend its maturity date to the earlier of the Qualified Financing Date or December 31, 2011. Additionally, Merhav and Ampal have agreed that, under certain circumstances, each will arrange for loans to Merhav Energies from time to time through third parties, directly or indirectly, for up to $15 million.
 
 
As stated above, as a condition to closing MAG’s purchase of a 25% equity stake in Merhav Energies, Merhav, MAG and Merhav Energies will enter into a Shareholders’ Agreement (the “Shareholders’ Agreement”), to provide for, among other things, (i) restrictions on the transfer of shares of Merhav Energies, (ii) a right of first refusal on transfers of shares of Merhav Energies, (iii) tag-along and drag-along rights on the transfer of shares of Merhav Energies, (iv) preemptive rights on the issuance of new shares of capital stock (or other equity interest) by Merhav Energies, subject to the anti-dilution rights of MAG, and (v) the right of MAG to designate 25% of the directors of Merhav Energies. In addition to preemptive rights under the Shareholders’ Agreement, MAG has been granted anti-dilution protection, which may result in the issuance of additional shares of Merhav Energies to MAG, in the event that, prior to end of the 180-day period following the commencement of the Project’s operations, Merhav sells, or Merhav Energies issues, shares of Merhav Energies at a per share price that is less than the per share price paid by MAG under the Exercise Agreement.
 
Merhav is a multinational corporation with interests in a range of sectors, including energy, infrastructure projects and agriculture. Merhav is a significant shareholder of Ampal and is wholly owned by Mr. Yosef A. Maiman, the President, CEO and member of the controlling shareholder group of Ampal. Because of the foregoing relationship, a special committee of the Board of Directors of Ampal composed of Ampal’s independent directors negotiated and approved the transaction. Houlihan Lokey Financial Advisors, Inc., which has been retained as financial advisor to the special committee, advised the special committee on this transaction.
 
11.          Services and Management Agreements
 
In February 2009, Ampal and Gadot entered into a management services agreement (intercompany transaction), according to which Ampal provides Gadot with management services for an annual consideration calculated as a percentage of Gadot's profits.
 
On December 30, 2010, Ampal entered into a management services agreement with Merhav, according to which Merhav provides the Company and its subsidiaries with management, marketing, financial, development and other administrative services for an annual consideration which will be determined annually and shall be equal to a percentage of the direct and indirect expenses incurred by Merhav in connection with providing services to or for the benefit of Ampal. The management fee shall be determined by the Special Committee of the Board of Directors of Ampal (composed solely of independent directors) at or around the end of each fiscal year.
 
On January 1, 2011, Ampal entered into an Aircraft Sharing Agreement with Merhav, according to which Ampal has a limited and non-exclusive right to use the aircraft possessed and operated by Merhav. For the usage of the aircraft, Ampal will pay Merhav a pro rata share of the fixed costs related to the aircraft (calculated annually based on the flight hours of the aircraft used by Ampal compared to the total flight hours of the aircraft, with a maximum amount of $500,000 per annum) and the direct costs and expenses of operating each flight for Ampal.
 
 
12

 
 
As stipulated above, Yosef A. Maiman, the Chairman, President and CEO of Ampal and a member of the controlling shareholder group of Ampal, is the sole owner of Merhav. Because of the foregoing relationship, a special committee of the Board of Directors composed of Ampal’s independent directors negotiated and approved the transactions between Ampal and Merhav.
 
12. 
Derivatives and Other Financial Instruments
 
The Company is exposed to certain risks relating to its ongoing business operations, including financial, market, political, and economic risks. The following discussion provides information regarding the Company's exposure to the risks of changing commodity prices, interest rates, and foreign currency exchange rates.
 
The Company’s derivative activities are subject to management's discretion.
 
The interest rate and foreign exchange contracts are held for purposes other than trading. They are used primarily to mitigate uncertainty and volatility, and in order to cover underlying exposures. A swap contract was entered into to convert some of the Company's NIS denominated debt in the amount of NIS 150 million (approximately $43.9 million) into U.S. Dollar denominated debt and to convert Israeli interest rates into LIBOR interest rates.
 
On April 1, 2009, the Company signed an interest rate swap contract in order to convert some of the Company's LIBOR interest rate denominated debt in the amount of $43.7 million into fixed interest rate debt, for a contractual term of 10 years.
 
Gadot
 
The Company uses foreign currency forward contracts to mitigate fluctuations in foreign currency exchange rates due to variations in payment or receipt of currencies other than the Company's functional currency. The Company uses contracts to purchase U.S. Dollars and sell Euros, contracts to purchase Euros and sell U.S. Dollars and contracts to purchase U.S. Dollars and sell NIS.
 
The Company enters into derivative financial instruments, including swaps and forward agreements. The Company reports the fair value of the derivatives on our balance sheet. The derivatives used are not designated as a hedging instrument under ASC 815. Changes in fair value are recognized in earnings in the period of change.
 
The following summarizes the gross fair market value of all derivative instruments and their locations in our consolidated balance sheet, and indicates which instruments are in an asset or liability position.
 
Asset Derivatives
_________________________________________________________________________________
 
        (U.S. Dollars in thousands)  
Derivative Instrument
 
Location
 
June 30, 2011
   
December 31, 2010
   
June 30, 2010
 
SWAP contracts
 
Other assets
  $ 7,406     $ 5,552     $ 889  
Foreign currency exchange contracts
 
Other assets
  $ 55       -     $ 57  
 
Liability Derivatives
________________________________________________________________________________
 
         (U.S. Dollars in thousands)  
Derivative Instrument
 
Location
 
June 30, 2011
   
December 31, 2010
   
June 30, 2010
 
SWAP contracts
 
Accounts payable, accrued expenses and others
  $ 415       -     $ 293  
Foreign currency exchange contracts
 
Accounts payable, accrued expenses and others
  $ 25       -     $ 29  
 
 
13

 
 
Statements of Operations
_________________________________________________________________________________
 
       
(U.S. Dollars in thousands)
 
       
Six months ended June 30,
 
Derivative Instrument
 
Location
 
2011
   
2010
 
SWAP contract
 
Translation loss
  $ (462 )   $ (624 )
Interest rate SWAP contract
 
Interest gain (loss)
  $ 1,902     (1,903     
Foreign currency exchange contracts
 
Translation gain
  $ 129     $ 1  
 
13.          Fair Value Measurements
 
 
Fair value is defined as the price that would be received to sell an asset or paid to transfer the liability (an exit price) in an orderly transaction between market participants and also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The fair value hierarchy used by the Company within ASC 820 distinguishes between three levels of inputs that may be utilized when measuring fair values including Level 1 inputs (using quoted prices in active markets for identical assets or liabilities), Level 2 inputs (using inputs other than Level 1 prices such as quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability) and Level 3 inputs (unobservable inputs supported by little or no market activity based on the Company's own assumptions used to measure assets and liabilities). A financial asset's or liability’s classification within the above hierarchy is determined based on the lowest level input that is significant to the fair value measurement.
 
 
The following section describes the valuation methodologies used by the Company to measure derivative contracts at fair value, including an indication of the level in the fair value hierarchy at which each instrument is generally classified. Where appropriate, the description includes details of the valuation models, the key inputs to those models, and any significant assumptions.
 
 
Derivative contracts are valued using quoted market prices and significant other observable and unobservable inputs. Such financial instruments consist of aluminum, energy, interest rate, and foreign exchange contracts. The fair values for the majority of these derivative contracts are based upon current quoted market prices. These financial instruments are typically exchange-traded and are generally classified within Level 1 or Level 2 of the fair value hierarchy depending on whether the exchange is deemed to be an active market or not.
 
Financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2011 consisted of the following (in thousands):
 
Fair Value Measurements as of:
           
 
   
June 30, 2011
   
December 31, 2010
 
   
Level 1
   
Level 2
   
Total
   
Level 1
   
Level 2
   
Total
 
Trading securities *
  $ 78     $ -     $ 78     $ 381     $ -     $ 381  
Available for sale securities *
    525       -       525       509       -       509  
Derivative assets **
    -       7,461       7,461       -       5,552       5,552  
Derivative liabilities **
    -       (440 )     (440 )     -       -       -  
Total
  $ 603     $ 7,021     $ 7,624     $ 890     $ 5,552     $ 6,442  
 
 
Marketable securities that are classified in Level 1 consist of available-for-sale and trading securities for which market prices are readily available. The fair value of derivative assets is determined based on inputs that can be derived from information available in publicly quoted markets. Unrealized gains or losses from available-for-sale securities are recorded in accumulated other comprehensive (loss) income.
 
 
* The trading securities and available-for-sale securities are mainly traded debentures.
 
** See Note 12.
 
 
14

 
 
The carrying amount of the Company's traded debentures as of June 30, 2011 is $292 million. The market value of such debentures, based on the closing price of those debentures on June 30, 2011 on the Tel Aviv Stock Exchange, was $247 million. The total carrying value of long-term loans as of June 30, 2011 was $347.1 million. The Company estimates that the fair value of the long-term loans approximates their carrying value, since substantially all of them bear non-fixed interest and there is no significant change in the credit risk of such loans.
 
Investment in EMG with a carrying amount of $361.3 million was written down to its fair value of $344.4 million, resulting in a loss of $16.9 million, which was included in loss for the period.
 
14.
Segment information presented below results primarily from operations in Israel.
 
The Chemical segment consists of Gadot which operates in the distribution and marketing of liquid chemicals for raw materials used in the chemical industry.
 
The Energy segment consists of the investment in EMG, an Egyptian joint stock company, which holds the right to supply and supplies natural gas to Israel through an underwater pipeline from Egypt to Israel. This investment is accounted for under the cost method.
 
The Leisure-time segment consists of an affiliate, Country Club Kfar Saba Ltd., the Company’s 51%-owned subsidiary, located in Israel.
 
The Finance segment consists of all other activities which are not part of any of the above segments.
 
   
SIX MONTHS ENDED JUNE 30,
   
THREE  MONTHS ENDED JUNE 30,
 
   
2011
   
2010 (*)
   
2011
   
2010 (*)
 
   
(Dollars in thousands)
   
(Dollars in thousands)
 
                         
Revenues:
                       
Chemicals
  $ 274,171     $ 236,324     $ 139,627     $ 118,118  
Finance
    3,341       3,750       2,024       938  
Leisure-time
    1,549       1,470       882       809  
      279,061       241,544       142,533       119,865  
Equity in earnings (losses) of affiliates
    179       (198 )     (2 )     (215 )
Total consolidated revenues
  $ 279,240     $ 241,346     $ 142,531     $ 119,650  
Pre-tax operating gain (loss):
                               
Chemicals
  $ (1,031 )   $ (1,109 )   $ 938     $ 997  
Finance
    (35,649 )     (9,323 )     (18,559 )     (361 )
Energy
    (16,923 )     --       (16,923 )     --  
Leisure-time
    103       58       119       (29 )
      (53,500 )     (10,374 )     (34,425 )     607  
Equity in earnings (losses) of affiliates
    179       (198 )     (2 )     (215 )
Total consolidated pretax gain (loss)
  $ (53,321 )   $ (10,572 )   $ (34,427 )   $ 392  
 
TOTAL ASSETS
 
JUNE 30,
2011
   
DECEMBER 31,
2010
 
             
Chemicals
  $ 491,897     $ 469,056  
Finance
    566,167       508,997  
Energy
    344,400       361,323  
Leisure-Time
    4,545       3,714  
Inter-segments adjustments
    (371,730 )     (357,654 )
Held for sale assets
    --       412,239  
Total consolidated assets
  $ 1,035,279     $ 1,397,675  
 
(*)  Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
 
15

 
 
15.
Midroog Ltd. (an affiliate of Moody's Investors Service) ("Midroog") currently rates Ampal's Series A, Series B and Series C Debentures (the "Debentures").
 
On May 26, 2011, Midroog downgraded Ampal's Debentures ratings by two notches, to BAA3 from BAA1 with a negative outlook. The Debentures were removed from Midroog's "Watchlist”.

Due to the above downgrading of the ratings of Ampal's Series C Debentures and according to the terms of the Series C debentures, the Series C debenture holders are entitled to additional interest payments which will be calculated as follows:
 
 
1.
The annual interest on Ampal's Series C Debentures since their issuance and until May 25, 2011 was 6.95%;
 
2.
The annual interest on Ampal's Series C Debentures from May 26, 2011 and thereafter will be 7.70%;
 
3.
The weighted average interest that Ampal shall pay its Series C Debentures holders on the upcoming interest payment date, September 7, 2011, will be 7.37% and therefore the interest to be paid on September 7, 2011 will be 3.685%;
 
4.
The annual interest on Ampal's Series C Debentures as reflected from the above weighted average interest is 7.40%;
 
5.
The annual interest on Ampal's Series C Debentures for the upcoming periods will be 7.70%; and
 
6.
The semi-annual interest on Ampal's Series C Debentures for the upcoming periods will be 3.85%.
 
16.
The following table summarizes securities that were not included in the calculations of diluted earnings per share of Class A Stock for the periods ended June 30, 2011 and 2010 because such shares are anti-dilutive.
 
(Shares in thousands)
 
Six Months ended
June 30,
   
Three Months ended
June 30,
 
   
2011
   
2010
   
2011
   
2010
 
                         
Shares resulting from Options and Rights
    4,110       3,783       4,110       3,783  
 
17. 
LEGAL PROCEEDINGS:
 
None.
 
18.
Subsequent Events
 
EMG Pipeline

From February 5, 2011 to March 15, 2011, from April 27, 2011 to June 9, 2011 and from July 4, 2011 to July 5, 2011, the supply of gas to EMG, and therefore to EMG’s Israeli clients, was interrupted due to damages in GASCO’s (the Egyptian gas transport company) pipeline serving EMG resulting from three alleged terror attacks on GASCO's gas pipeline. Neither EMG's site nor EMG's pipeline were damaged in the three attacks.
 
On July 12, 2011, the supply of gas to EMG, and therefore to EMG’s Israeli clients, was interrupted due to an explosion in a valve station of GASCO's gas pipeline, approximately 20 kilometers west of EMG's site at Al Arish, due to an alleged terror attack. Following the explosion EGAS initiated its standard shut down procedure affecting gas transportation throughout the Sinai area and gas supply to Jordan, Lebanon, Syria; to major Egyptian industries and gas consumers in the Sinai; and to EMG.
 
On July 30, 2011, in the wake of violent incidents in El-Arish, Egypt, there was an attempt to cause damage to the EMG site near El-Arish. The security forces on site returned fire, prevented any penetration of the EMG site and repelled the attack.

EMG reports that the July 30, 2011 incident will not affect its operations once EGPC resumes supply after it was interrupted due to the July 12, 2011 explosion.
 
 
16

 
 
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
 
CRITICAL ACCOUNTING POLICIES
 
The preparation of Ampal-American Israel Corporation's ("Ampal", and collectively with its subsidiaries, the "Company") consolidated financial statements is in conformity with accounting principles generally accepted in the United States ("GAAP") which requires management to make estimates and assumptions in certain circumstances that affect amounts reported in the accompanying consolidated financial statements and related footnotes. Actual results may differ from these estimates. To facilitate the understanding of Ampal’s business activities, described below are certain Ampal accounting policies that are relatively more important to the portrayal of its financial condition and results of operations and that require management’s subjective judgments. Ampal bases its judgments on its experience and various other assumptions that it believes to be reasonable under the circumstances. Please refer to Note 1 to Ampal’s consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2010 for a summary of all of Ampal’s significant accounting policies.
 
No significant updates have occurred since the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2010.
 
Revenue Recognition
 
Revenue is recognized when (a) the significant risks and rewards of ownership of the goods have been transferred to the buyer; (b) the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; (c) the amount of revenue can be measured reliably; (d) it is probable that the economic benefits associated with the transaction will flow to the Company; and (e) the costs incurred or to be incurred in respect of the transaction can be measured reliably.
 
Chemical income derives from the following activities: sales of a wide range of liquid chemicals, providing maritime shipping services of chemicals by ships and providing other services which include logistics and storage services for chemicals.
 
Revenue from services is recognized as follows:
 
 
·
Revenues arising from the provision of marine transport services proportionally over the period of the marine transport services. As to voyages uncompleted in which a loss is expected, a full provision is made in the amount of the expected loss.
 
 
·
Revenues from chemical brokerage commissions are recognized when the right to receive them is created.
 
 
·
Rental income is recorded over the rental period. Revenues from services provided to country club subscribers are recognized ratably over the contractual period.
 
 
·
Income from other services is recognized over the period during which those services are performed.
 
Recently Adopted and Recently Issued Accounting Pronouncements
 
In June 2011, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update No. 2011-05 ("ASU 2011-05") which amended the comprehensive income presentation guidance. The amendment requires entities to report components of comprehensive income in either a continuous statement of comprehensive income or two separate but consecutive statements. The guidance is effective for interim and annual periods beginning after December 15, 2011. The Company is currently evaluating the potential impact of ASU 2011-05 on its financial statements.

In May 2011, the FASB issued Accounting Standards Update No. 2011-04 ("ASU 2011-04") for Fair Value Measurements and Disclosures (Topic 820). The amendment clarifies the existing guidance and adds new disclosure requirements. The guidance is effective for interim and annual periods beginning after December 15, 2011. The Company is currently evaluating the potential impact of ASU 2011-04 on its financial statements.
 
In December 2010, the FASBissued Accounting Standards Update No. 2010-28 (“ASU 2010-28”)for Intangibles - Goodwill and Other (Topic 350): "Intangibles - Goodwilland Other: When to Perform Step 2 of the Goodwill Impairment Test forReporting Units with Zero or Negative Carrying Amounts." ASU 2010-28impacted reporting units with zero or negative carrying amounts and requiredan additional test to be performed to determine whether goodwill has beenimpaired and to calculate the amount of that impairment. The adoptiondid not have a material impact on the Company's financial statements. The amendments in this Update are effective for fiscal years, and interimperiods within those years, beginning after December 15, 2010. Early adoptionis not permitted. The adoption did not have a material impact on the Company'sfinancial statements.
 
 
17

 
 
Results of Operations

Chemicals

Changes in pricing and demand for chemicals

The overall demand for chemical products, especially commodity chemicals, is highly dependent on general economic conditions. In the past quarter, the price of crude oil slightly decreased, accordingly the prices of commodity chemicals as well as the average freight prices decreased.
 
In the six months ended June 30, 2011 and 2010, the Company included the following certain data of Gadot Chemical Tankers and Terminals Ltd. ("Gadot"):
 
   
2011
      2010 (*)  
   
(U.S. dollars in millions)
 
Chemical income
  $ 274.2     $ 236.3  
Chemical expense
  $ 249.2     $ 216.5  
Marketing expense
  $ 5.4     $ 3.9  
Other expense (mainly general and administrative)
  $ 16.2     $ 23.9  
Interest expense
  $ 4.3     $ 3.1  
Pre-tax operating income
  $ 3.1     $ 0.1  
 
(*) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
Six months ended June 30, 2011 compared to six months ended June 30, 2010
 
The Company recorded a consolidated net loss attributable to Ampal’s shareholders of $22.1 million for the six months ended June 30, 2011, compared to a net loss of $10.0 million for the corresponding period in 2010. The loss in 2011 is primarily attributable to the impairment of the investment in EMG and increase in income tax expenses (resulting from decrease in deferred income taxes) in the amount of $16.9 million and $14.1 million, respectively, and translation loss, offset by a $28.9 million capital gain that was recorded from the sale of 012 Smile (“012”).
 
In the six months ended June 30, 2011, the Company recorded $5.4 million of marketing expense, as compared to a $3.9 million marketing expense in the corresponding period in 2010. These expenses are attributable to Gadot and composed mainly of salary and commission expenses. The increase is primarily the result of the increase in the Chemical revenue compared to the corresponding period in 2010.
 
In the six months ended June 30, 2011, the Company recorded $30.9 million of general, administrative and other expenses, as compared to $24.4 million in the corresponding period in 2010. The increase resulted mainly from the revaluation of the New Israeli Shekel (“NIS”) compared to the U.S. Dollar and the increase in payments on account of annual management fees.
 
In the six months ended June 30, 2011, the Company recorded $11.5 million of net loss attributable to noncontrolling interests, as compared to $2.7 million of net gain attributable to noncontrolling interests in the corresponding period in 2010. This loss are mainly attributable to the impairment of the investment in EMG and translation loss in the notes issued to the partners in Merhav Ampal Energy, LP, an Israeli limited partnership (the "Joint Venture"), resulting from the revaluation of the NIS compared to the U.S. Dollar.
 
In the six months ended June 30, 2011, the Company recorded a $22.7 million interest expense, as compared to a $17.7 million interest expense for the corresponding period in 2010. The interest expense relates to the financing the Company obtained in order to purchase Gadot, the Company's debentures, the Company's notes payable and the interest expense resulting from the swap agreements. The increase in interest expense relates, mainly, to the issuance of the Company’s Series C debentures.
 
In the six months ended June 30, 2011, the Company recorded a $7.3 million translation loss, as compared to a $10.6 million translation gain for the corresponding period in 2010. The increase in translation loss is related to a change in the valuation of the NIS as compared to the U.S. Dollar, which increased 3.8% in the six months ended June 30, 2011, as compared to a decrease of 2.6% for the corresponding period in 2010.

In the six months ended June 30, 2011, the Company recorded a gain of $0.9 million due to the repurchase of the debentures.

The Company recorded a $0.2 million net gain in Equity in earnings of affiliates for the six months ended June 30, 2011, compared to $0.2 million net loss in Equity in earnings of affiliates for the corresponding period in 2010.
 
 
18

 
 
Results of operations analyzed by segments for the six months ended June 30:
 
   
2011
    2010(*)  
   
(U.S. Dollars in thousands)
 
Revenues:
             
               
Chemicals
  $ 274,171     $ 236,324  
Finance
    3,341       3,750  
Leisure-time
    1,549       1,470  
      279,061       241,544  
Equity in earnings (losses) of affiliates
    179       (198 )
Total consolidated revenues
  $ 279,240     $ 241,346  
 
(*) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
The Chemicals income relates solely to Gadot and was derived from the following activities: sales of a wide range of liquid and solid chemicals, providing maritime shipping services of chemicals by ships and providing other services which include logistics and storage services for chemicals.
 
In the six months ended June 30, 2011, the Company recorded $279.2 million in revenue which was comprised of $274.2 million in the Chemicals segment, $3.3 million in the Finance segment, $1.5 million in the Leisure-time segment, and a $0.2 million in Equity in earnings of affiliates, as compared to $241.3 million for the same period in 2010, which was comprised of $236.3 million in the Chemicals segment, $3.8 million in the Finance segment and $1.5 million in the Leisure-time segment, and a $0.2 million in Equity losses of affiliates. The increases in chemical commodity sale prices (revenues) and some volume growth positively contributed to gross margin as a result of utilizing inventory quantities and price.
 
   
2011
    2010(*)  
   
(U.S. Dollars in thousands)
 
Expenses:
             
               
Chemicals
  $ 275,202     $ 239,050  
Finance
    38,989       11,456  
Energy
    16,923       --  
Leisure-time
    1,447       1,412  
Total
  $ 332,561     $ 251,918  
 
(*) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
In the six months ended June 30, 2011, the Company recorded $332.6 million in expenses which was comprised of $275.2 million of expenses in the Chemicals segment, $39.0 million of expenses in the Finance segment, $16.9 million of expenses in the Energy segment and a $1.4 million of expenses in the Leisure-time segment, as compared to $251.9 million in expenses for the same period in 2010 which was comprised of $239.1 million of expenses in the Chemicals segment, $11.5 million of expenses in the Finance segment and a $1.4 million of expenses in the Leisure-time segment. Chemical commodity pricing is derivative of crude oil pricing. During the six months ended June 30, 2011, the price of crude oil decreased, which led to a moderate decrease in chemical commodity prices. The increase in the expenses of the Energy segment is primarily attributable to the impairment of the investment in EMG in the amount of $16.9 million. The increase in the Finance segment expenses is primarily attributable to the translation loss related to a 3.8% increase in value of the NIS to the U.S. Dollar in the six months ended June 30, 2011, as compared to a decrease of 2.6% for the corresponding period in 2010, and the increase in loans payable.
 
Three months ended June 30, 2011 compared to three months ended June 30, 2010
 
The Company recorded a consolidated net loss of $39.3 million for the three months ended June 30, 2011, compared to a net loss of $2.8 million for the corresponding period in 2010. The increase in loss in the period ended June 30, 2011 is primarily attributable to the impairment of the investment in EMG and increase in income tax expenses (resulting from a decrease in deferred income taxes) in the amount of $16.9 million and $14.1 million, respectively, and translation loss.
 
In the three months ended June 30, 2011, the Company recorded $2.8 million of marketing and sales expense, as compared to a $1.7 million marketing and sales expense in the corresponding period in 2010. These expenses are attributable to Gadot and composed mainly of salary and commission expenses. The increase is primarily the result of the increase in the Chemical revenue compared to the corresponding period in 2010.
 
 
19

 
 
In the three months ended June 30, 2011, the Company recorded $17.1 million of general, administrative and other expense, as compared to $12.0 million in the corresponding period in 2010. The increase resulted mainly from the revaluation of the NIS compared to the U.S. Dollar and the increase in payments on account of annual management fees.
 
In the three months ended June 30, 2011, the Company recorded $9.3 million of net loss attributable to noncontrolling interests, as compared to $4.2 million of net gain attributable to noncontrolling interests in the corresponding period in 2010. These losses are mainly attributable to the impairment of the investment in EMG and translation losses in the notes issued to the partners in the Joint Venture, resulting from the revaluation of the NIS compared to the U.S. Dollar.
 
In the three months ended June 30, 2011, the Company recorded a $13.0 million interest expense, as compared to a $11.5 million interest expense for the corresponding period in 2010. The interest expense relates to the financing the Company obtained in order to purchase Gadot, the Company's debentures, the Company's notes payable and the interest expense resulting from the swap agreements. The increase in interest expense relates, mainly, to the Company’s issuance of the Series C debentures.
 
In the three months ended June 30, 2011, the Company recorded a $3.4 million translation loss, as compared to a $14.0 million translation income for the corresponding period in 2010. The monetary value of denominated NIS balances reported on our balance sheet changes with currency exchange rates resulting in the translation gain or loss. The increase in translation loss is related to a change in the valuation of the NIS as compared to the U.S. Dollar, which increased 1.9% in the three months ended June 30, 2011, as compared to a decrease of 4.4% for the corresponding period in 2010.
 
The Company recorded a minor net loss in Equity in losses of affiliates for the three months ended June 30, 2011, compared to a minor net loss of $0.2 million in the corresponding period in 2010.
 
Results of operations analyzed by segments for the three months ended June 30:
 
   
2011
    2010(*)  
   
(U.S. Dollars in thousands)
 
Revenues:
             
               
Chemicals
  $ 139,627     $ 118,118  
Finance
    2,180       938  
Leisure-time
    882       809  
      142,689       119,865  
Equity in losses of affiliates
    (2 )     (215 )
Total
  $ 142,687     $ 119,650  
 
 (*) Retroactively adjusted to reflect acquisition under common control (see Note 9)

The Chemicals income relates solely to Gadot and was derived from the following activities: sales of a wide range of liquid chemicals, providing maritime shipping services of chemicals by ships and providing other services which include logistics and storage services for chemicals.
 
In the three months ended June 30, 2011, the Company recorded $142.7 million in revenue which was comprised of $139.6 million in the Chemicals segment, $2.2 million in the Finance segment and $0.9 million in the Leisure-time segment, as compared to $119.7 million for the same period in 2010, which was comprised of $118.1 million in the Chemicals segment, $0.9 million in the Finance segment and $0.8 million in the Leisure-time segment. The increase in Chemicals revenues is primarily attributable to the recovery in the markets, especially in Europe, which led to an increase in quantities sold and product prices. The demand for chemical carriers shows moderate growth during the three months ended June 30, 2011 and average freight prices were stable.
 
   
2011
    2010(*)  
   
(U.S. Dollars in thousands)
 
Expenses:
             
               
Chemicals
  $ 138,689     $ 118,737  
Finance
    20,739       13,710  
Energy
    16,923       --  
Leisure-time
    763       838  
      177,114       133,285  
Translation Gain
    --       (14,027 )
Total
  $ 177,114     $ 119,258  
 
(*) Retroactively adjusted to reflect acquisition under common control (see Note 9)
 
 
20

 
 
In the three months ended June 30, 2011, the Company recorded $177.1 million in expenses which was comprised of $138.7 million of expenses in the Chemicals segment, $20.7 million of expenses in the Finance segment, $16.9 million of expenses in the Energy segment and a $0.8 million of expenses in the Leisure-time segment, as compared to $119.3 million in expenses for the same period in 2010, which was comprised of $118.7 million in the Chemicals segment, $10.3 million in the Finance segment and a $0.8 million in the Leisure-time segment offset by $10.6 million translation gain. During the period of three months ended June 30, 2011, the price of crude oil slightly decreased, which led to a moderate decrease in chemical commodity prices.
 
The increase in the Energy segment expenses is primarily attributable to the impairment of the investment in EMG in the amount of $16.9 million. The increase in the Finance segment expenses is primarily attributable to the translation loss related to a 1.9% increase in value of the NIS to the U.S. Dollar in the three months ended June 30, 2011, as compared to a decrease of 4.4% for the corresponding period in 2010, and the increase in loans payable.
 
Income taxes
 
In the six-month period ended June 30, 2011, the Company reported a tax expense of $21.2 million (out of which $6.9 million classified as discontinued operations) as compared to approximately $0.5 million of tax benefit in the corresponding period in 2010. The tax expense which was recorded in 2011 was attributable mainly to the decrease in deferred income taxes in the amount of $14.1 million which was recorded due to the impairment of the investments in EMG and the capital gain from the sale of 012. The Company intends to apply a tax planning strategy of selling all or a portion of its investments in order to utilize the net deferred income taxes that are attributable to foreign tax credits and loss carryforwards arising in the U.S., due to unrealized gain from several investments which the Company holds.
 
Liquidity and Capital Resources
 
Cash Flows
 
On June 30, 2011, cash, cash equivalents and marketable securities were $98.0 million, as compared with $34.2 million at December 31, 2010. The increase is mainly attributable to the sale of 012's shares.
 
As of June 30, 2011, the Company had $0.6 million of marketable securities as compared to $0.9 million as of December 31, 2010.
 
The Company may also receive cash from operations and investing activities and amounts available under credit facilities, as described below. The Company believes that these sources are sufficient to fund the current requirements of operations, capital expenditures, investing activities and other financial commitments of the Company for the next 12 months. However, to the extent that contingencies and payment obligations described below and in other parts of this report require the Company to make unanticipated payments, the Company would need to further utilize these sources of cash. The Company may need to draw upon its other sources of cash, which may include additional borrowing, refinancing of its existing indebtedness or liquidating other assets, the value of which may also decline.
 
In addition, Ampal’s interest in Gadot has been pledged and cash equivalents equal to $1.0 million have been allocated as a compensating balance for various loans provided to the Company.
 
Cash flows from operating activities
 
Net cash used in operating activities totaled approximately $43.6 million for the six months ended June 30, 2011, compared to approximately $8.4 million provided by operating activities for the corresponding period in 2010. The increase in cash used in operating activities is primarily attributable to the increase in other assets and inventories and the increase in the net loss from continuing operations which increased by $57.6 million, mainly from the increase in interest expenses and the revaluation of the NIS, as compared to the corresponding period in 2010.
 
Cash flows from investing activities
 
Net cash provided from investing activities totaled approximately $6.6 million for the six months ended June 30, 2011, compared to approximately $9.1 million provided from investing activities for the corresponding period in 2010.
 
Cash flows from financing activities
 
Net cash used in financing activities was approximately $59.8 million for the six months ended June 30, 2011, compared to approximately $51.3 million of net cash provided from financing activities for the corresponding period in 2010. The change in cash used in financing activities is primarily attributable to the notes payable repaid due to the sale of 012’s shares in the six months ended June 30, 2011, as compared to the notes payable received for the acquisitions of 012’s business in the corresponding period in 2010.
 
 
21

 
 
Investments
 
EMG
 
As of today, EMG has entered into gas supply contracts as detailed in the following table:

Client
 
Billion Cubic Meters (“BCM”) (annually)
 
Term
Israel Electric Corp.
 
2.1
 
15 years (+5 years)
Israel Corporation Ltd.
 
1.4
 
20 years
Dorad Energy Ltd.
 
0.75
 
17 years (+5 years)
Other Contracts
 
0.55
   
Total
 
4.8
   
Signed Options
 
1.5
   
Total including Options
 
6.3
   
 
The Company evaluates the carrying value amount of its interest in EMG periodically in connection with the preparation of its financial statements.  In light of the recent developments in Egypt, the Company obtained an updated valuation from an independent valuator for the quarters ended June 30, 2011 and March 31, 2011. The periodic independent valuations obtained by the Company to assist in its preparation of financial statements customarily indicate a range of values depending on underlying assumptions.  In the recent independent valuation, due to uncertainties in Egypt, the lower end of the indicated valuation range was materially lower than in the past and lower than the value at which EMG is carried on the Company's balance sheet. Management assessed the investment to determine if the decline in fair value was other than temporary. Based on these assessments, management determined that the decline in fair value of the investment was other than temporary and the Company recorded charges of $16.9 million.
 
The principal factors affecting valuation are the price, quantity, delivery dates and reliability of the gas as well as the discount rate.  An adverse change in any of these factors could result in additional material reduction in the value of EMG and additional reduction in the carrying value amount of the asset on the Company's balance sheet.  The Company will continue to evaluate developments with regard to EMG and will make determinations each fiscal period as to whether an impairment charge is appropriate.
 
Investments
 
In the six months ended June 30, 2011, the Company made additional investments in the amount of a $0.6 million loan to Global Wind Energy.
 
Debt
 
Notes issued to institutional investors in Israel, the convertible note issued to Merhav M.N.F Ltd. ("Merhav") and other loans payable pursuant to bank borrowings are either in U.S. Dollars, linked to the Consumer Price Index (the "CPI") in Israel or in unlinked NIS, with interest rates varying depending upon their linkage provisions and mature between 2011 and 2019.
 
The Company finances its general operations and other financial commitments through bank loans from Bank Hapoalim, Union Bank of Israel Ltd. ("UBI") and Israel Discount Bank Ltd. ("IDB"). As of June 30, 2011, the outstanding indebtedness under these bank loans totaled $89.4 million, and the loans mature between 2011 and 2019.
 
 
22

 
 
 
Series A Debentures
Series B Debentures
Series C Debentures
 
par value in NIS in thousands
U.S. Dollars in thousands
par value in NIS in thousands
U.S. Dollars in thousands
par value in NIS in thousands
U.S. Dollars in thousands
Date of issuance
November 20, 2006
April 29, 2008
September 13, 2010
Linkage
Israeli CPI
 
Israeli CPI
 
Israeli CPI
 
Interest
5.75%
6.60%
6.95%+0.75% (*)
Maturity date
November 2015
January 2016
September 2019
Issuance
250,000
57,978
577,823
166,856
170,000
45,093
Purchased
25,813
7,130
83,628
23,226
5,262
1,633
Balance as of June 30, 2011
224,187
76,358
494,195
163,101
164,738
49,822
Deposits held by trustees
 
--
 
11,280
 
12,209
 
(*) see the description below.
 
On September 13, 2010, Ampal completed a public offering in Israel of NIS 170.0 million (approximately $45.0 million) aggregate principal amount of its Series C debentures, due in 2019. The debentures are linked to the CPI and carry an annual interest rate of 6.95%. The Series C debentures rank pari passu with Ampal’s unsecured indebtedness. The debentures will be repaid in six equal annual installments commencing on September 7, 2014, and the interest will be paid semi-annually. As of June 30, 2011, the outstanding debt under the debentures amounts to $49.8 million. Ampal deposited an amount equal to $12.2 million with Ziv Haft Trust Company Ltd. in accordance with a trust agreement dated August 31, 2010, to secure the first four years' worth of payments of interest on the debentures.
 
On May 26, 2011, Midroog Ltd. (an affiliate of Moody's Investors Service) ("Midroog") downgraded Ampal's Series A, Series B and Series C Debentures' (the "Debentures") ratings by two notches, to BAA3 from BAA1 with a negative outlook. The Debentures were removed from Midroog's "Watchlist”.

Due to the above downgrading of the ratings of Ampal's Series C Debentures and according to the terms of the Series C debentures, the Series C debenture holders are entitled to additional interest payments which will be calculated as follows:
 
 
1.
The annual interest on Ampal's Series C Debentures since their issuance and until May 25, 2011 was 6.95%;
 
2.
The annual interest on Ampal's Series C Debentures from May 26, 2011 and thereafter will be 7.70%;
 
3.
The weighted average interest that Ampal shall pay its Series C Debentures holders on the upcoming interest payment date, September 7, 2011, will be 7.37% and therefore the interest to be paid on September 7, 2011 will be 3.685%;
 
4.
The annual interest on Ampal's Series C Debentures as reflected from the above weighted average interest is 7.40%;
 
5.
The annual interest on Ampal's Series C Debentures for the upcoming periods will be 7.70%; and
 
6.
The semi-annual interest on Ampal's Series C Debentures for the upcoming periods will be 3.85%.
 
Ampal’s Board of Directors approved a repurchase program of Ampal’s Series A, Series B and Series C debentures (the "Debentures") that are traded on the Tel Aviv Stock Exchange (“TASE”). Under the program, Ampal is authorized to repurchase the Debentures in a total amount not in excess of the NIS equivalent of $30 million. The repurchases may be made in transactions in TASE or outside TASE, in block trades or otherwise. The program may be suspended or discontinued at any time.
 
The repurchase program will be funded using Ampal’s available cash and by possible future borrowings.
 
 
23

 
 
During the six months ended June 30, 2011, the Company repurchased 5,699,104 Series A Debentures, 6,975,458 Series B Debentures and 5,262,084 Series C Debentures for an aggregate amount of $5.0 million. The Company recorded a gain of $0.9 million due to the repurchase of the debentures.
 
Ampal funded the Gadot acquisition with a combination of available cash and the proceeds of the credit facility, dated November 29, 2007 (the "Credit Facility"), between MAG and IDB, for approximately $60.7 million, which amount was increased, on the same terms and conditions, on June 3, 2008 by approximately $11.3 million in order to fund the second stage of the transaction and on September 23, 2008 by approximately $15.4 million in order to fund the third stage of the transaction. The Credit Facility is divided into two equal loans of approximately $43.7 million. The first loan is a revolving loan that has no principal payments and may be repaid in full or in part on December 31 of each year until 2019, when a single balloon payment will become due. The second loan also matures in 2019, has no principal payments for the first one and a half years, and shall thereafter be paid in equal installments over the remaining 9.5 years of the term. As of June 30, 2011, the outstanding debt under the loan amounts to $35.8 million. Interest on both loans accrues at a floating rate equal to LIBOR plus 2% and is payable on a current basis. Ampal has guaranteed all the obligations of MAG under the Credit Facility and Ampal’s interest in Gadot has also been pledged to IDB as a security for the Credit Facility.  Yosef Maiman has agreed with IDB to maintain ownership of a certain amount of the Company’s Class A Stock. The Credit Facility contains customary affirmative and negative covenants for credit facilities of this type.
 
As of June 30, 2011, the Company has a $3.3 million loan with UBI that bears interest at an annual rate of LIBOR plus 2% to be repaid in six annual installments commencing on April 2, 2008 and various other loans with UBI in the aggregate amount of $3.1 million linked to the CPI, bearing interest of 2.9% to be repaid during 2011.
 
As of June 30, 2011, the Company has a $107.3 million loan from institutional investors who own 50% of Merhav Ampal Energy Holdings, LP. The loan is not linked to the CPI, bears no interest and is repayable upon agreement by both parties.
 
The Company has a short-term loan from Bank Hapoalim in the aggregate amount of $3.5 million that bears interest at an annual rate of 2.84%, to be repaid by January 1, 2012.
 
As of June 30, 2011, Gadot had $2.6 million outstanding under its other debentures. These debentures are not convertible into shares and are repayable in five equal annual installments on September 15 of each of the years 2008 through 2012. The outstanding balance of the principal of the debentures bears interest at an annual rate of 5.3%. The principal and interest of the debentures are linked to the CPI and the interest is payable in semi-annual installments on March 15 and September 15 of each of the years 2006 through 2012.
 
As of June 30, 2011, Gadot has short-term loans, including current maturities, payable in the amount of $129.0 million and long-term loans payable in the amount of $142.4 million. The various short term-loans payable are either unlinked or linked to the U.S. Dollar or Euro and bear interest at rates between 0.7% to 7.8%. The various long-term loans payable are either unlinked or linked to the CPI or linked to the U.S. Dollar or Euro and bear interest at annual rates between 1.44% to 7.01%.
 
The weighted average interest rates and the balances of these short-term borrowings at June 30, 2011 and December 31, 2010 were 3.8% on $141.6 million and 3.8% on $131.9 million, respectively.

Our significant contractual obligations as of June 30, 2011 are summarized in the following table (in thousands):
 
Contractual Obligations
 
Total
   
Less than
1 year
   
1 – 3 years
   
3-5 years
   
More than
5 years
 
Short-Term Debt:
                             
Gadot - working capital
  $
117,765
    $
117,765
                   
Gadot - current maturities
  $ 11,272     $ 11,272                    
Ampal - revolving credit line
  $ 3,897     $ 3,897                    
Ampal  - current maturities
  $ 8,703     $ 8,703                    
Debentures – current maturities
  $ 47,892     $ 47,892                    
Long-Term Debt:
                                 
Ampal
  $ 184,750             $ 9,619     $ 7,952     $ 167,179  
Gadot:
                                       
Vessels
  $ 58,098             $ 7,400     $ 5,592     $ 45,106  
Other
  $
84,278
            $
20,015
    $ 20,292     $ 43,971  
Debentures
  $
243,931
            $ 98,325     $ 112,385     $ 33,221  
Total Debt
  $ 760,586     $
189,529
    $
135,359
    $ 146,221     $ 289,477  
 
As of June 30, 2011, the Company had issued guarantees in the aggregate principal amount of $59.5 million. These include:
 
 
 1.
A $10.1 million guarantee on indebtedness incurred by Bay Heart in connection with the development of property. There can be no guarantee that Bay Heart will generate sufficient cash to repay its outstanding indebtedness without relying on the Company’s guarantee; and
 
 2.
A $49.4 million guarantee of outstanding indebtedness of Gadot.
 
 
24

 
 
Some of the Company's credit contracts are subject to covenant clauses, whereby the Company is required to meet certain key performance indicators. Certain subsidiaries did not fulfill the required covenants.
 
Due to these breaches of covenant clauses, the bank is contractually entitled to request early repayment of the outstanding amount. The outstanding balance is classified as a current liability. The bank has not requested early repayment of the loans.
 
Off-Balance Sheet Arrangements
 
Other than the foreign currency contracts specified below, the Company has no off-balance sheet arrangements.
 
FOREIGN CURRENCY CONTRACTS
 
The Company’s derivative financial instruments consist of foreign currency forward exchange contracts to purchase or sell U.S. Dollars. These contracts are utilized by the Company, from time to time, to manage risk exposure to movements in foreign exchange rates. None of these contracts have been designated as hedging instruments. These contracts are recognized as assets or liabilities on the balance sheet at their fair value, which is the estimated amount at which they could be settled, based on market prices or dealer quotes, where available, or based on pricing models. Changes in fair value are recognized currently in earnings.
 
As of June 30, 2011, the Company had open foreign currency forward exchange contracts to purchase U.S. Dollars and sell Euros in the amount of $1.5 million and to purchase Euros and sell U.S. Dollars in the amount of $2.6 million.
 
FORWARD LOOKING STATEMENTS
 
This Quarterly Report (including but not limited to factors discussed above, in the “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” as well as those discussed elsewhere in this Quarterly Report on Form 10-Q) includes forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and information relating to the Company that are based on the beliefs of management of the Company as well as assumptions made by and information currently available to the management of the Company. When used in this Quarterly Report, the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” and similar expressions, as they relate to the Company or the management of the Company, identify forward-looking statements. Such statements reflect the current views of the Company with respect to future events or future financial performance of the Company, the outcome of which is subject to certain risks and other factors which could cause actual results to differ materially from those anticipated by the forward-looking statements, including among others, the economic and political conditions in Israel and the Middle East and the global business and economic conditions in the different sectors and markets where the Company’s portfolio companies operate.
 
Should any of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results or outcomes may vary from those described herein as anticipated, believed, estimated, expected, intended or planned. These risks and uncertainties may include, but are not limited to, those described in this report, in Part II, Item 1A. Risk Factors and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2010, and those described from time to time in our future reports filed with the Securities and Exchange Commission. The Company assumes no obligation to update or revise any forward-looking statements.
 
 
25

 
 
ITEM 4. CONTROLS AND PROCEDURES
 
Disclosure Controls and Procedures
 
The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective. Notwithstanding the foregoing, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports.
 
Changes in Internal Control Over Financial Reporting
 
There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect the Company’s internal control over financial reporting.
 
 
26

 
 
Part II       –    OTHER INFORMATION
 
Item 1.             Legal Proceedings:

None.
 
Item 1A.         RISK FACTORS
 
In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2010, as updated in our Quarterly Report on Form 10-Q for the quarter ended March 31, 2011, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K and our March 31, 2011 Quarterly Report on Form 10-Q are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
 
Item 2.             Unregistered Sales of Equity Securities and Use of Proceeds.
 
None.
 
Item 3.             Defaults upon Senior Securities
 
None.
 
Item 4.             [Removed and Reserved]
 
Item 5.             Other Information.
 
None.
 
Item 6.              Exhibits.
 
 
(a)
Exhibits:
 
11.1
Schedule Setting Forth Computation of Earnings Per Share of Class A Stock.
 
31.1
Certification of Yosef A. Maiman pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
31.2
Certification of Irit Eluz pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
32.1
Certification of Yosef A. Maiman and Irit Eluz pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
27

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
AMPAL-AMERICAN ISRAEL CORPORATION
   
 
By: /s/ Yosef A. Maiman
 
 
Yosef A. Maiman
 
Chairman of the Board
 
President & Chief Executive Officer
 
(Principal Executive Officer)
   
 
By: /s/ Irit Eluz
 
 
Irit Eluz
 
CFO and Senior Vice President,
 
Finance and Treasurer
 
(Principal Financial Officer)
   
 
By: /s/ Zahi Ben-Atav
 
 
Zahi Ben-Atav
 
VP Accounting and Controller
 
(Principal Accounting Officer)
   
Date: August 4, 2011
 
 
 
28

 
 
AMPAL-AMERICAN ISRAEL CORPORATION AND SUBSIDIARIES
 
Exhibit Index
 
Exhibit  No.  Description
 
11.1
Schedule Setting Forth Computation of Earnings Per Share of Class A Stock.
 
31.1
Certification of Yosef A. Maiman pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
31.2
Certification of Irit Eluz pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
32.1
Certification of Yosef A. Maiman and Irit Eluz pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
29